An "unexpected" role for EMT transcription factors in hematological development and malignancy

Front Immunol. 2023 Aug 3:14:1207360. doi: 10.3389/fimmu.2023.1207360. eCollection 2023.

Abstract

The epithelial to mesenchymal transition (EMT) is a fundamental developmental process essential for normal embryonic development. It is also important during various pathogenic processes including fibrosis, wound healing and epithelial cancer cell metastasis and invasion. EMT is regulated by a variety of cell signalling pathways, cell-cell interactions and microenvironmental cues, however the key drivers of EMT are transcription factors of the ZEB, TWIST and SNAIL families. Recently, novel and unexpected roles for these EMT transcription factors (EMT-TFs) during normal blood cell development have emerged, which appear to be largely independent of classical EMT processes. Furthermore, EMT-TFs have also begun to be implicated in the development and pathogenesis of malignant hematological diseases such as leukemia and lymphoma, and now present themselves or the pathways they regulate as possible new therapeutic targets within these malignancies. In this review, we discuss the ZEB, TWIST and SNAIL families of EMT-TFs, focusing on what is known about their normal roles during hematopoiesis as well as the emerging and "unexpected" contribution they play during development and progression of blood cancers.

Keywords: EMT; blood cells; hematopoiesis; leukemia; malignancy; stem cells.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epithelial-Mesenchymal Transition
  • Female
  • Hematologic Neoplasms*
  • Humans
  • Leukemia* / genetics
  • Neoplasms* / genetics
  • Pregnancy
  • Transcription Factors / genetics

Substances

  • Transcription Factors

Grants and funding

CC is supported by National Health and Medical Research Council Ideas Grant funding (GNT1182318), and a Victorian Cancer Agency Mid-Career Fellowship (MCRF22015).